InsiderTrades.com logo
50-year Wall Street legend: “Sell this tech stock NOW”
From Chaikin Analytics   |   Ad
Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.
You can watch for it for free, right here.

TLSI Insider Trading

Insider Ownership Percentage: 32.80%
Insider Buying (Last 12 Months): $72,440.40
Insider Selling (Last 12 Months): $49.50

TriSalus Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at TriSalus Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TriSalus Life Sciences Share Price & Price History

Current Price: $4.53
Price Change: ▲ Price Increase of +0.1 (2.26%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for TLSI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.

TriSalus Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2024Mats WahlstromDirectorBuy2,040$4.16$8,486.402,040View SEC Filing Icon  
9/12/2024Mary T SzelaCEOBuy7,520$5.20$39,104.00377,382View SEC Filing Icon  
9/10/2024Mary T SzelaCEOBuy5,000$4.97$24,850.00369,862View SEC Filing Icon  
8/28/2024George Kelly MartinDirectorSell9$5.50$49.50247,176View SEC Filing Icon  
See Full Table
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

SEC Filings (Institutional Ownership Changes) for TriSalus Life Sciences (NASDAQ:TLSI)

2.58% of TriSalus Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TLSI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TriSalus Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024Virtu Financial LLC19,875$92K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC200,427$0.92M0.0%+45.4%0.657%Search for SEC Filing on Google Icon
11/15/2024Vestcor Inc23,376$0.11M0.0%N/A0.077%Search for SEC Filing on Google Icon
11/15/2024MSD Partners L.P.39,999$0.18M0.1%N/A0.131%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC14,376$66K0.0%N/A0.047%Search for SEC Filing on Google Icon
8/15/2024Duquesne Family Office LLC426,921$2.36M0.1%+35.1%1.572%Search for SEC Filing on Google Icon
8/12/2024Highbridge Capital Management LLC214,545$1.18M0.0%N/A0.790%Search for SEC Filing on Google Icon
8/2/2024Wolverine Asset Management LLC43,480$0.24M0.0%N/A0.160%Search for SEC Filing on Google Icon
5/7/2024Anson Capital Inc.24,415$0.24M0.3%-30.3%0.091%Search for SEC Filing on Google Icon
5/1/2024Connecticut Wealth Management LLC44,606$0.44M0.0%-22.0%0.167%Search for SEC Filing on Google Icon
4/23/2024Tyche Wealth Partners LLC10,000$98K0.0%-62.5%0.037%Search for SEC Filing on Google Icon
1/30/2024Tyche Wealth Partners LLC26,664$0.23M0.1%N/A0.101%Search for SEC Filing on Google Icon
1/25/2024HC Advisors LLC101,736$0.86M0.5%N/A0.387%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TriSalus Life Sciences logo
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.
Read More on TriSalus Life Sciences

Today's Range

Now: $4.53
Low: $4.33
High: $4.65

50 Day Range

MA: $4.25
Low: $3.67
High: $4.67

52 Week Range

Now: $4.53
Low: $3.33
High: $10.42

Volume

38,153 shs

Average Volume

31,359 shs

Market Capitalization

$138.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of TriSalus Life Sciences?

TriSalus Life Sciences' top insider shareholders include:
  1. Mary T Szela (CEO)
  2. George Kelly Martin (Director)
  3. Mats Wahlstrom (Director)
Learn More about top insider investors at TriSalus Life Sciences.

Who are the major institutional investors of TriSalus Life Sciences?

TriSalus Life Sciences' top institutional shareholders include:
  1. Geode Capital Management LLC — 0.66%
  2. MSD Partners L.P. — 0.13%
  3. Vestcor Inc — 0.08%
  4. Virtu Financial LLC — 0.07%
  5. Walleye Capital LLC — 0.05%
Learn More about top institutional investors of TriSalus Life Sciences stock.

Which major investors are buying TriSalus Life Sciences stock?

During the last quarter, TLSI stock was bought by institutional investors including:
  1. Geode Capital Management LLC
  2. MSD Partners L.P.
  3. Vestcor Inc
  4. Virtu Financial LLC
  5. Walleye Capital LLC
Within the previous year, these company insiders have bought TriSalus Life Sciences stock:
  1. Mary T Szela (CEO)
  2. George Kelly Martin (Director)
Learn More investors buying TriSalus Life Sciences stock.
50-year Wall Street legend: “Sell this tech stock NOW”
From Chaikin Analytics   |   Ad
Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.
You can watch for it for free, right here.